CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial.

Jerkeman, M

CHOP versus MACOP-B in aggressive lymphoma--a Nordic Lymphoma Group randomised trial. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Sep 1999 - 1079-86 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0923-7534

10.1023/a:1008392528248 doi


Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bleomycin--administration & dosage
Cyclophosphamide--administration & dosage
Disease-Free Survival
Doxorubicin--administration & dosage
Female
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Methotrexate--administration & dosage
Middle Aged
Multivariate Analysis
Prednisolone--administration & dosage
Prognosis
Quality of Life
Survival Rate
Time Factors
Treatment Failure
Vincristine--administration & dosage